Provectus Biopharmaceuticals, Inc. (PNK:PVCT) Q4 2024 Earnings Call Transcript

Provectus Biopharmaceuticals, Inc. (PNK:PVCT) Q4 2024 Earnings Call Transcript November 14, 2024

Alyssa Barry: Good afternoon, good morning, good evening, depending on where you are. Welcome to Provectus Biopharmaceuticals Fourth Quarter Investor Update. My name is Alyssa Barry, Co-Founder and Principal of Investor Relations firm Alliance Advisors IR. I am hosting today’s call. Ed Pershing, Chairman of Provectus’ Board of Directors and Chief Executive Officer; and Dominic Rodriguez, Board...